These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25982916)

  • 41. Steady-state trough serum and epithelial lining fluid concentrations of teicoplanin 12 mg/kg per day in patients with ventilator-associated pneumonia.
    Mimoz O; Rolland D; Adoun M; Marchand S; Breilh D; Brumpt I; Debaene B; Couet W
    Intensive Care Med; 2006 May; 32(5):775-9. PubMed ID: 16550370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Teicoplanin population pharmacokinetic analysis in hospitalized patients.
    Soy D; López E; Ribas J
    Ther Drug Monit; 2006 Dec; 28(6):737-43. PubMed ID: 17164688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme.
    Lamont E; Seaton RA; Macpherson M; Semple L; Bell E; Thomson AH
    J Antimicrob Chemother; 2009 Jul; 64(1):181-7. PubMed ID: 19411678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loading dose required to achieve rapid therapeutic teicoplanin trough plasma concentration in patients with multidrug-resistant gram-positive infections.
    Wang JT; Liao HI; Wu Lin FL; Chang SC
    Basic Clin Pharmacol Toxicol; 2012 May; 110(5):416-20. PubMed ID: 22309355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Population Pharmacokinetics and Pharmacodynamics of Teicoplanin and C-Reactive Protein in Hospitalized Patients With Gram-Positive Infections.
    Ogami C; Tsuji Y; Muraki Y; Mizoguchi A; Okuda M; To H
    Clin Pharmacol Drug Dev; 2020 Feb; 9(2):175-188. PubMed ID: 30934169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of arterio-venous haemofiltration on teicoplanin elimination.
    Hillaire-Buys D; Peyriere H; Lobjoie E; Bres J; Ossart M; Despaux E
    Br J Clin Pharmacol; 1995 Jul; 40(1):95-7. PubMed ID: 8527277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Glycopeptides].
    Hayashi I
    Nihon Rinsho; 2001 Apr; 59(4):761-70. PubMed ID: 11305003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age- and gender-related differences in teicoplanin levels in paediatric patients.
    Strenger V; Hofer N; Rödl S; Hönigl M; Raggam R; Seidel MG; Dornbusch HJ; Sperl D; Lackner H; Schwinger W; Sovinz P; Benesch M; Urlesberger B; Urban C
    J Antimicrob Chemother; 2013 Oct; 68(10):2318-23. PubMed ID: 23702837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Significance of High Trough Concentration of Teicoplanin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection.
    Sato Y; Tokimatsu I; Suzuki Y; Itoh H; Hiramatsu K; Kadota J
    Chemotherapy; 2014; 60(4):274-8. PubMed ID: 25926288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Influence of arteriovenous hemofiltration on teicoplanin pharmacokinetics].
    Choufane S; Lobjoie E; Tinturier F
    Ann Fr Anesth Reanim; 1996; 15(8):1168-72. PubMed ID: 9636789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Albumin levels predict survival in patients with heart failure and preserved ejection fraction.
    Liu M; Chan CP; Yan BP; Zhang Q; Lam YY; Li RJ; Sanderson JE; Coats AJ; Sun JP; Yip GW; Yu CM
    Eur J Heart Fail; 2012 Jan; 14(1):39-44. PubMed ID: 22158777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors for decreased teicoplanin trough concentrations during initial dosing in critically ill patients.
    Yoshida T; Yoshida S; Okada H; Suzuki A; Niwa T; Suzuki K; Ohmori T; Kobayashi R; Baba H; Suzuki K; Murakami N; Itoh Y; Ogura S
    Pharmazie; 2019 Feb; 74(2):120-124. PubMed ID: 30782263
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacokinetics of multiple doses of teicoplanin in Chinese elderly critical patients.
    Wang S; Lin F; Ruan J; Ye H; Wang L
    Expert Rev Clin Pharmacol; 2018 May; 11(5):537-541. PubMed ID: 29506414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High variability of teicoplanin concentration in patients with continuous venovenous hemodiafiltration.
    Lim SK; Lee SA; Kim CW; Kang E; Choi YH; Park I
    Hemodial Int; 2019 Jan; 23(1):69-76. PubMed ID: 30714672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics.
    Ulldemolins M; Roberts JA; Wallis SC; Rello J; Lipman J
    J Antimicrob Chemother; 2010 Aug; 65(8):1771-8. PubMed ID: 20530507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Inter-individual and intra-individual pharmacokinetic variability during teicoplanin therapy in geriatric patients].
    Uhart M; Leroy B; Michaud A; Maire P; Bourguignon L
    Med Mal Infect; 2013 Jul; 43(7):295-8. PubMed ID: 23906420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of Teicoplanin Trough Values After the Recommended Loading Dose in Children With Associated Safety Analysis.
    Yamada T; Kubota T; Yonezawa M; Nishio H; Kanno S; Yano T; Kobayashi D; Egashira N; Takada H; Hara T; Masuda S
    Pediatr Infect Dis J; 2017 Apr; 36(4):398-400. PubMed ID: 27977550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma and tonsillar tissue pharmacokinetics of teicoplanin following intramuscular administration to children.
    Aarons L; Rowland M; Khan A; Taborelli G; Ferrea G; Tarantino V; Fioredda F; Rosina-Parenti R; Cavenaghi L; Borgonovi M
    Eur J Pharm Sci; 1998 Oct; 6(4):265-70. PubMed ID: 9795079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Bayesian approach to drug disposition evaluation: application to teicoplanin.
    Ferrante L; Bompadre S; Cingolani ML; Leone L
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):410-4. PubMed ID: 7582399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inflammatory factors for hypoalbuminemia in Japanese peritoneal dialysis patients.
    Shioya M; Yoshida T; Kasai K; Furuya R; Kato A; Mori N; Matsumoto Y; Kumagai H
    Nephrology (Carlton); 2013 Aug; 18(8):539-44. PubMed ID: 23718260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.